Preventing, Delaying and Reversing the Progression of Type I Diabetes
Files
Download Transcript, Episode 15 (83 KB)
Loading...
Document Type
Podcast
Hosts
Michael Smith
Featured Speaker
Mark Clements, MD, PhD
Length of Episode
13:00
Description
The Division of Pediatric Endocrinology and Diabetes is committed to providing patients the best medical care possible.
This commitment goes hand in hand with their dedication to discovering and pioneering the latest treatment methods through ongoing clinical research.
Their research areas include a vast range of topics associated with endocrinology, including diabetes, growth and growth hormone.
At Children’s Mercy Kansas City, approximately 200 children, adolescents and young adults are diagnosed with type I diabetes each year.
Patient volume, combined with a diverse patient population, the broad geographic area covered, and a full-service program, means Children’s Mercy is well positioned to conduct research on diabetes prevention, and serve as an Affiliate of the National Institutes of Health’s TrialNet.
The work TrialNet and Children’s Mercy do today may help prevent type I diabetes tomorrow or at least make it easier to control by preserving beta cell mass.
Mark Clements, MD is here to discuss how the goal is to identify individuals who have the genetic predisposition, but who haven’t develop the autoimmunity and have not experienced destruction of beta cells in order to preserve their beta cell mass and prevent the development of type I diabetes in these individuals.
Publication Date
8-17-2015
Recommended Citation
Smith, Michael and Clements, Mark A., "Preventing, Delaying and Reversing the Progression of Type I Diabetes" (2015). Transformational Pediatrics Podcast. 15.
https://scholarlyexchange.childrensmercy.org/transformational-peds_podcast/15
